Enteroporc Coli AC

Authorised

This medicine is authorised for use in the European Union

neonatal piglet colibacillosis (recombinant, inactivated) / Clostridium perfringens vaccine (inactivated)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Enteroporc Coli AC : EPAR - Medicine overview

Reference Number: EMA/540999/2020

Product information

Enteroporc Coli AC : EPAR - Product information

Enteroporc Coli AC : EPAR - All authorised presentations

Product details

• Name of medicine:
  Enteroporc Coli AC
• Active substance:
  • inactivated fimbrial adhesins of Escherichia coli
  • clostridium perfringens type A/C toxoids
• International non-proprietary name (INN) or common name:
  • neonatal piglet colibacillosis (recombinant, inactivated)
  • Clostridium perfringens vaccine (inactivated)

Pharmacotherapeutic group

• Immunologicals for suidae
• Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium

Authorisation details

• EMA product number:
  EMEA/V/C/005149

Assessment history

Changes since initial authorisation of medicine

Enteroporc Coli AC : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Enteroporc Coli AC : EPAR - Public assessment report

Adopted Reference Number: Enteroporc Coli AC : EPAR

CVMP summary of positive opinion for Enteroporc Coli AC

Adopted Reference Number: EMA/CVMP/489228/2020